The Sulfonamides Market is estimated at US$154.6 million in 2026 and is projected to grow at a CAGR of 5.8% to reach US$242.7 million by 2034.
Its value chain includes active ingredient suppliers, pharmaceutical manufacturers, veterinary product companies, distributors, hospitals, pharmacies, and clinical end users. Core applications include bacterial infection treatment, veterinary therapeutics, combination drug regimens, hospital care, and outpatient anti infective prescribing.
This product will be delivered within 1-3 business days.
Market Overview
The Sulfonamides Market covers pharmaceutical and veterinary anti infective products based on sulfonamide compounds used across human medicine, animal health, and selected specialty therapeutic applications.Its value chain includes active ingredient suppliers, pharmaceutical manufacturers, veterinary product companies, distributors, hospitals, pharmacies, and clinical end users. Core applications include bacterial infection treatment, veterinary therapeutics, combination drug regimens, hospital care, and outpatient anti infective prescribing.
Key Companies Analysed
- Pfizer
- Teva Pharmaceutical Industries
- Sun Pharmaceutical
- Dr. Reddy’s Laboratories
- Viatris
- Aurobindo Pharma
- Cipla
- Lupin
- Zydus Lifesciences
- Torrent Pharmaceuticals
- Amneal Pharmaceuticals
- Hikma Pharmaceuticals
- Alkem Laboratories
- Apotex
- Sandoz
- Sanofi
- Merck & Co
- Bayer
- Novartis
- Abbott
Geographic Coverage
- North America - Market data and outlook to 2034
- United States
- Canada
- Mexico
- Europe - Market data and outlook to 2034
- Germany
- United Kingdom
- France
- Italy
- Spain
- Netherlands
- Switzerland
- Poland
- Sweden
- Russia
- Asia-Pacific - Market data and outlook to 2034
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Malaysia
- Vietnam
- Middle East and Africa - Market data and outlook to 2034
- Saudi Arabia
- South Africa
- Iran
- UAE
- Egypt
- South and Central America - Market data and outlook to 2034
- Brazil
- Argentina
- Chile
- Peru
Report Delivery and Support
- Updated PDF report and an MS Excel workbook containing market tables and figures.
- 7-day post-sale analyst support for clarifications and in-scope supplementary data.
- Complimentary report update covering the latest available data and relevant market developments.
This product will be delivered within 1-3 business days.
Table of Contents
1. Contents and Report Guide
2. Global Sulfonamides Market Overview
3. Sulfonamides Market Dynamics
4. Sulfonamides Market Strategic Analysis
5. Global Sulfonamides Market Size, Share and Forecast, 2025-2034
6. North America Sulfonamides Market Outlook to 2034
7. Europe Sulfonamides Market Outlook to 2034
8. Asia-Pacific Sulfonamides Market Outlook to 2034
9. Middle East and Africa Sulfonamides Market Outlook to 2034
10. South and Central America Sulfonamides Market Outlook to 2034
11. Sulfonamides Market Competitive Landscape
12. Appendix
Companies Mentioned
- Pfizer
- Teva Pharmaceutical Industries
- Sun Pharmaceutical
- Dr. Reddy’s Laboratories
- Viatris
- Aurobindo Pharma
- Cipla
- Lupin
- Zydus Lifesciences
- Torrent Pharmaceuticals
- Amneal Pharmaceuticals
- Hikma Pharmaceuticals
- Alkem Laboratories
- Apotex
- Sandoz
- Sanofi
- Merck & Co
- Bayer
- Novartis
- Abbott
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 160 |
| Published | October 2026 |
| Forecast Period | 2026 - 2034 |
| Estimated Market Value ( USD | $ 154.6 Million |
| Forecasted Market Value ( USD | $ 242.7 Million |
| Compound Annual Growth Rate | 5.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 20 |
